CDK2 INHIBITORS AND METHODS OF USING THE SAME

The present disclosure relates generally to Cyclin-dependent kinase 2 (CDK2) inhibiting chemical compounds and uses thereof in the inhibition of the activity of CDK2. The disclosure also provides pharmaceutically acceptable compositions comprising compounds disclosed herein and methods of using said...

Full description

Saved in:
Bibliographic Details
Main Authors MICHOWSKI, WOJTEK, PORTER, JR, KIRMAN, LOUISE CLARE, RIPPER, JUSTIN, SCHWARTZ, CARL ERIC, FEUTRILL, JOHN
Format Patent
LanguageEnglish
French
Published 29.12.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present disclosure relates generally to Cyclin-dependent kinase 2 (CDK2) inhibiting chemical compounds and uses thereof in the inhibition of the activity of CDK2. The disclosure also provides pharmaceutically acceptable compositions comprising compounds disclosed herein and methods of using said compounds and compositions in the treatment of various disorders related to CDK2 activity. La présente invention concerne de manière générale des composés chimiques inhibiteurs de la kinase cycline-dépendante 2 (CDK2) et leurs utilisations dans l'inhibition de l'activité de la CDK2. L'invention concerne également des compositions pharmaceutiquement acceptables comprenant les composés de l'invention et des procédés d'utilisation desdits composés et compositions dans le traitement de divers troubles liés à l'activité de la CDK2.
AbstractList The present disclosure relates generally to Cyclin-dependent kinase 2 (CDK2) inhibiting chemical compounds and uses thereof in the inhibition of the activity of CDK2. The disclosure also provides pharmaceutically acceptable compositions comprising compounds disclosed herein and methods of using said compounds and compositions in the treatment of various disorders related to CDK2 activity. La présente invention concerne de manière générale des composés chimiques inhibiteurs de la kinase cycline-dépendante 2 (CDK2) et leurs utilisations dans l'inhibition de l'activité de la CDK2. L'invention concerne également des compositions pharmaceutiquement acceptables comprenant les composés de l'invention et des procédés d'utilisation desdits composés et compositions dans le traitement de divers troubles liés à l'activité de la CDK2.
Author FEUTRILL, JOHN
MICHOWSKI, WOJTEK
KIRMAN, LOUISE CLARE
SCHWARTZ, CARL ERIC
PORTER, JR
RIPPER, JUSTIN
Author_xml – fullname: MICHOWSKI, WOJTEK
– fullname: PORTER, JR
– fullname: KIRMAN, LOUISE CLARE
– fullname: RIPPER, JUSTIN
– fullname: SCHWARTZ, CARL ERIC
– fullname: FEUTRILL, JOHN
BookMark eNrjYmDJy89L5WTQdXbxNlLw9PPwdPIM8Q8KVnD0c1HwdQ3x8HcJVvB3UwgN9vRzVwjxcFUIdvR15WFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8c6OxkZGpibGlo6GxkQoAQAuIiY4
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate INHIBITEURS DE CDK2 ET LEURS PROCEDES D'UTILISATION
ExternalDocumentID CA3225439A1
GroupedDBID EVB
ID FETCH-epo_espacenet_CA3225439A13
IEDL.DBID EVB
IngestDate Fri Aug 16 05:48:22 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CA3225439A13
Notes Application Number: CA20223225439
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221229&DB=EPODOC&CC=CA&NR=3225439A1
ParticipantIDs epo_espacenet_CA3225439A1
PublicationCentury 2000
PublicationDate 20221229
PublicationDateYYYYMMDD 2022-12-29
PublicationDate_xml – month: 12
  year: 2022
  text: 20221229
  day: 29
PublicationDecade 2020
PublicationYear 2022
RelatedCompanies CEDILLA THERAPEUTICS, INC
RelatedCompanies_xml – name: CEDILLA THERAPEUTICS, INC
Score 3.4391396
Snippet The present disclosure relates generally to Cyclin-dependent kinase 2 (CDK2) inhibiting chemical compounds and uses thereof in the inhibition of the activity...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title CDK2 INHIBITORS AND METHODS OF USING THE SAME
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221229&DB=EPODOC&locale=&CC=CA&NR=3225439A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT4MwEL8s06hvOjXOr_TB8EaUwqY8EAMtCBpgGWj2tgClyV7m4jD--14Jm77oW9Mm1_bSu-uv17sDuBkZVSnxHqyP7cLWrVJIvawKqkup3IelLahQD_pxMg5frefZaNaDxSYWps0T-tUmR0SJqlDem1Zfr34esXj7t3J9Wy6w6_0xyB2udeiYoiJGAM09x5-kPGUaYw5ztWTqqHOLttdFoLSDt-h7JQz-m6eCUla_LUpwCLsTJLZsjqBXLwewzzaF1wawF3f-bmx2orc-Bp3xF0qiJIy8KE-nGXETTmI_D1OekTQgqn7GE8lDn2Ru7J8ACfychTrOO9_ucc7c7QrNU-gj9K_PgBiyllIYwlbxqzW9KxD-yFqYsjIraj2IIQz_JHP-z9gFHChmqW8Z1L6EfvPxWV-hcW3K65Yt3yUGedk
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8QNOKbokb87IPZ26J0A93DYka7uQnbCEzDG9nWNeEFiMz473tdBvqib02bXNtL766_Xu8O4K7XzTOJ92C9b6WWbmZC6lmeUl1K5T7MLEGFetAPo77_Zr7OerMGLLaxMFWe0K8qOSJKVI7yXlb6ev3ziMWrv5Wb-2yBXatnL7G5VqNjiooYATQf2O445jHTGLOZo0UTW51btL0OAqU9vGE_KmFw3wcqKGX926J4R7A_RmLL8hgaxbINLbYtvNaGg7D2d2OzFr3NCeiMDykJIj8YBEk8mRIn4iR0Ez_mUxJ7RNXPeCGJ75KpE7qnQDw3Yb6O8853e5wzZ7dC4wyaCP2LcyBdWUgpusJS8asFfUgR_shCGDI3cmo-iQ50_iRz8c_YLbT8JBzNR0E0vIRDxTj1RYNaV9AsPz6LazS0ZXZTsegbBrl8zA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=CDK2+INHIBITORS+AND+METHODS+OF+USING+THE+SAME&rft.inventor=MICHOWSKI%2C+WOJTEK&rft.inventor=PORTER%2C+JR&rft.inventor=KIRMAN%2C+LOUISE+CLARE&rft.inventor=RIPPER%2C+JUSTIN&rft.inventor=SCHWARTZ%2C+CARL+ERIC&rft.inventor=FEUTRILL%2C+JOHN&rft.date=2022-12-29&rft.externalDBID=A1&rft.externalDocID=CA3225439A1